Jocko Fuel Swaps Fadogia Agrestis for PLT’s TestFACTOR in COMBAT TESTED 3.0 Reformulation
Event summary
- Jocko Fuel launches COMBAT TESTED 3.0 on April 16, 2026, replacing 300 mg of Fadogia agrestis with 325 mg of PLT’s TestFACTOR.
- TestFACTOR is backed by four clinical studies showing up to 19% increase in total testosterone and 20% in free testosterone.
- Product available direct-to-consumer via jockofuel.com, Amazon, and select retail partners beginning mid-April 2026.
- TestFACTOR recognized with the 'Ingredient Idol' award at SupplySide Global.
The big picture
Jocko Fuel’s reformulation underscores a broader industry shift toward clinically validated ingredients in performance nutrition. The partnership with PLT Health Solutions highlights the growing demand for transparent, science-backed formulations, particularly among health-conscious men in their mid-40s and beyond. This move could set a new standard for testosterone optimization supplements, pressuring competitors to follow suit with similarly substantiated products.
What we're watching
- Market Response
- How consumers will respond to the clinically validated TestFACTOR in COMBAT TESTED 3.0.
- Competitive Differentiation
- Whether Jocko Fuel’s science-backed approach will sustain its market position against trend-driven competitors.
- Ingredient Validation
- The pace at which TestFACTOR gains broader adoption in the men’s health supplement category.
Related topics